BioNexus Gene Lab Corp. (BGLC) vs Ping An Biomedical Co., Ltd. (PASW)
A side-by-side comparison of BioNexus Gene Lab Corp. and Ping An Biomedical Co., Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGLC
BioNexus Gene Lab Corp.
$1.24IndustrialsDelayed quote: Oct 6, 2026, 12:50 PM EDT
PASW
Ping An Biomedical Co., Ltd.
$0.12IndustrialsDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — BGLC vs PASW
growth of $100 · dividends reinvested · last 1yBGLC -77.5% (-77.5%/yr)PASW -89.3% (-89.3%/yr)BGLC compounded faster over this window
BGLC PASW
BGLC vs PASW: by the numbers
- •BGLC is the larger company ($3M vs $2M market cap).
- •Both run net losses; PASW's is the smaller (-37.57% vs -82.36% net margin).
Metrics side by side
Valuation
| Metric | BGLC | PASW |
|---|---|---|
| P/S ratio | 0.96 | N/A |
| P/B ratio | 0.39 | 0.36 |
Profitability
| Metric | BGLC | PASW |
|---|---|---|
| Gross margin | 11.64% | 2.78% |
| Operating margin | -42.54% | -43.05% |
| Net margin | -82.36% | -37.57% |
| ROE | -33.11% | -28.36% |
| ROIC | -32.71% | -26.57% |
Growth (annualized)
| Metric | BGLC | PASW |
|---|---|---|
| Revenue CAGR (5Y) | -31.68% | N/A |
| Total return CAGR (5Y) | -61.00% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.